Gene · 5226
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Some pyrroles as inhibitors of the pentose phosphate pathways enzymes: An in vitro and molecular docking study. | J Mol Recognit | 2024 | 38514991 | PubTator, text mining | PubMed |
| Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. | J Exp Clin Cancer Res | 2024 | 38291438 | PubTator, text mining | PubMed |
| Cutaneous Leishmania mexicana Infections in the United States: Defining Strains Through Endemic Human Pediatric Cases in Northern Texas. | medRxiv | 2024 | 38260515 | PubTator, text mining | PubMed |
| Fused Enzyme Glucose-6-Phosphate Dehydrogenase::6-Phosphogluconolactonase (G6PD::6PGL) as a Potential Drug Target in Giardia lamblia, Trichomonas vaginalis, and Plasmodium falciparum. | Microorganisms | 2024 | 38257939 | PubTator, text mining | PubMed |
| The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? | Antioxidants (Basel) | 2024 | 38247494 | PubTator, text mining | PubMed |
| Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review. | Neurooncol Adv | 2024 | 38221979 | PubTator, text mining | PubMed |
| Evaluating the relationship between Clinical G6PD enzyme activity and gene variants. | PeerJ | 2024 | 38188142 | PubTator, text mining | PubMed |
| Metabolic reprogramming driven by EZH2 inhibition depends on cell-matrix interactions. | J Biol Chem | 2024 | 37992808 | PubTator, text mining | PubMed |
| Natural flavonoids as promising 6-phosphogluconate dehydrogenase inhibitor candidates: In silico and in vitro assessments. | Arch Pharm (Weinheim) | 2024 | 37933686 | PubTator, text mining | PubMed |
| Decoding m6A mRNA methylation by reader proteins in liver diseases. | Genes Dis | 2024 | 37692496 | PubTator, text mining | PubMed |
| Structural and functional characterization of 6-phosphogluconate dehydrogenase in Plasmodium falciparum (3D7) and identification of its potent inhibitors. | J Biomol Struct Dyn | 2024 | 37599457 | PubTator, text mining | PubMed |
| The potential role of Hippo pathway regulates cellular metabolism via signaling crosstalk in disease-induced macrophage polarization. | Front Immunol | 2023 | 38274792 | PubTator, text mining | PubMed |
| NADPH Dynamics: Linking Insulin Resistance and β-Cells Ferroptosis in Diabetes Mellitus. | Int J Mol Sci | 2023 | 38203517 | PubTator, text mining | PubMed |
| High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5. | Cancers (Basel) | 2023 | 38201437 | PubTator, text mining | PubMed |
| The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers. | Int J Mol Sci | 2023 | 38139067 | PubTator, text mining | PubMed |
| A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC. | Cancer Metab | 2023 | 38111012 | PubTator, text mining | PubMed |
| G6PDH as a key immunometabolic and redox trigger in arthropods. | Front Physiol | 2023 | 38046951 | PubTator, text mining | PubMed |
| Differential interactome mapping of aggregation prone/prion-like proteins under stress: novel links to stress granule biology. | Cell Biosci | 2023 | 38041189 | PubTator, text mining | PubMed |
| Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. | J Clin Invest | 2023 | 38038136 | PubTator, text mining | PubMed |
| Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy. | Redox Biol | 2023 | 38035663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5226/papers?page=3